IDEAS home Printed from https://ideas.repec.org/a/wly/mgtdec/v40y2019i1p16-36.html
   My bibliography  Save this article

Returns on different types of investment in the global pharmaceutical industry

Author

Listed:
  • Jörg Mahlich
  • B. Burcin Yurtoglu

Abstract

Using stock market data of 10,550 publicly listed companies between 1987 and 2012, we study the marginal returns on investment for a large sample of pharmaceutical firms and compare them with returns on investment of firms from other industries. We also disentangle effects of different types of investments on total returns, namely, investment in advertising, research and development (R&D), fixed capital, and acquisitions. Our results suggest that the return of pharmaceutical companies on total investments is higher compared with a large number of nonpharmaceutical companies for the U.S. subsample in the first half of the observation period whereas no such difference can be found for non‐U.S. firms. We also find that the return–cost ratio has declined during our observation period, with the biggest drop for European firms. R&D investments generate the highest, and advertising investments the lowest returns.

Suggested Citation

  • Jörg Mahlich & B. Burcin Yurtoglu, 2019. "Returns on different types of investment in the global pharmaceutical industry," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 40(1), pages 16-36, January.
    • Handle: RePEc:wly:mgtdec:v:40:y:2019:i:1:p:16-36
    DOI: 10.1002/mde.2977
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/mde.2977
    Download Restriction: no
    File URL: https://libkey.io/10.1002/mde.2977?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jörg Mahlich & Arne Bartol & Srirangan Dheban, 2021. "Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis," Health Economics Review, Springer, vol. 11(1), pages 1-10, December.
    2. Julen Castillo‐Apraiz & Jesus Matey, 2020. "Customizing competitive strategy to entry timing: Implications for firm performance in the pharmaceutical industry," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 41(6), pages 976-985, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:mgtdec:v:40:y:2019:i:1:p:16-36. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/7976 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.